Tanakan 40mg tablets film-coated

País: Armênia

Língua: inglês

Origem: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Ingredientes ativos:

ginkgo biloba extract

Disponível em:

Beaufour Ipsen Industrie

Código ATC:

N06DX02

DCI (Denominação Comum Internacional):

ginkgo biloba extract

Dosagem:

40mg

Forma farmacêutica:

tablets film-coated

Unidades em pacote:

(30/3x10/) blisters, (90/6x15/) blisters

Tipo de prescrição:

OTC

Status de autorização:

Registered

Data de autorização:

2015-02-06

Características técnicas

SUMMARY OF PRODUCT CHARACTERISTICS
1. NAME OF THE MEDICINAL PRODUCT
TANAKAN, coated tablets 40 mg
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Ginkgo _(Ginkgo biloba L.)_ (quantified extract) containing 24 % of
ginkgo heterosides and 6 % of ginkgolides‐
bilobalide ................................................. 40.00 mg
For one coated tablet.
For the full list of
excipients, see section 6.1.
3. PHARMACEUTICAL FORM
Coated tablet.
4. CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
‐ Treatment aimed at symptomatic management of chronic pathological
cognitive and neurosensorial deficit in
the elderly patient (excluding Alzheimer's disease and other
dementia).
‐ Symptomatic treatment of intermittent claudication in chronic
obliterating arteriopathies of the lower limbs
(stage 2).
N.B. This indication relies on double blind clinical trials versus
placebo, showing an increase in the walking
perimeter of at least 50% in 50 to 60% of patients treated versus 20
to 40% of patients following only health and
dietetic rules.
‐ Adjunct treatment of losses in acuity and troubles of the visual
field presumed to be of vascular origin.
‐ Adjunct treatment of losses in auditive acuity and of certain
syndromes of vertigo and/or tinnitus presumed to
be of vascular origin.
‐ Improvement of Raynaud's phenomenon.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Oral route.
3 tablets per day, spread through the day.
Tablets should be taken with a half‐glass of water, during meals.
4.3 CONTRAINDICATIONS
This medicine is contra‐indicated in the following circumstance :
Hypersensitivity to one of the components of the tablet, age under 18,
erosive gastritis, stomach or duodenal
ulcer in acute period, acute brain disorders, acute myocardial
infarction, pregnancy and lactation, low blood
coagulability, galactosemia, lactase insufficiency, lactose
intolerance, glucose or galactose malabsorption.
4.4 SPECIAL WARNINGS AND SPECIAL PRECAUTIONS FOR USE
_SPECIAL WARNINGS _
Since this medicinal product contains lactose, it is
contra‐indic